NEW YORK – Roche announced on Thursday that it has renewed and expanded its global business partnership agreement with Sysmex and will continue to offer Sysmex's hematology products.
Under the updated nonexclusive agreement, the companies will also jointly explore more sustainable diagnostic solutions, they said in a statement. Further terms were not disclosed.
"Developing our partnerships in the field of diagnostics even further and addressing enduring eco-social challenges represents a significant milestone in advancing our alliance to the next level," Sysmex President Kaoru Asano said in a statement. "Together, we firmly believe in making even greater contributions to our customers in laboratories and creating a sustainable society."
The firms first entered into their commercial and research and development partnership in 1998 and signed the global business partnership agreement in 2020, which included Roche's distribution of Sysmex hematology products. Under that agreement, the companies also said they would use their IT platforms to improve customer experience in the short term and eventually improve clinical decision-making with the systems. They also agreed to work together to establish a joint framework to standardize cybersecurity measures.
In 2018, the companies entered into a nonexclusive agreement to offer total laboratory solutions, allowing customers to buy clinical chemistry, immunochemistry, and hematology testing products from one vendor. The global business partnership agreement also includes the total laboratory solutions deal.